Microbiological and epidemiological investigation of the Neisseria meningitidis serogroup A epidemic in Niger in 2009: Last wave before the introduction of the serogroup A meningococcal conjugate vaccine?

Epidemiology and Infection

Volumn 139, Issue 11, 2011, Pages 1656-1660

  Collard, J M ^a   Maman, Z ^b   Abani, A ^b   Mainasara, H B ^a   Djibo, S ^a   Yacouba, H ^b   Maitournam, R ^b   Sidikou, F ^a   Nicolas, P ^c   Rocourt, J ^a   Jusot, J F ^a  

^a Centre de Recherche Medicale et Sanitaire Niamey   (Niger)

^b Ministry of Health Niamey   (Niger)

^c SERVICE DE SANTÉ DES ARMÉES   (France)

Author keywords

Bacterial meningitis; epidemic; meningococcal disease; Niger

Indexed keywords

AMOXICILLIN; AMPICILLIN; CEFTRIAXONE; CHLORAMPHENICOL; MENINGOCOCCUS VACCINE; PENICILLIN G; POLYSACCHARIDE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CEREBROSPINAL FLUID ANALYSIS; DISEASE SURVEILLANCE; EPIDEMIC MENINGITIS; HAEMOPHILUS INFLUENZAE; HUMAN; INFECTION CONTROL; MASS IMMUNIZATION; NIGER; PUBLIC HEALTH SERVICE; SEASONAL VARIATION; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; EPIDEMICS; HUMANS; MASS VACCINATION; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS; NIGER;

EID: 80053560405     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268810003092     Document Type: Article

References (12)

1. Chanteau S, et al. Scaling up of PCR-based surveillance of bacterial meningitis in the African meningitis belt: indisputable benefits of multiplex PCR assay in Niger. Transactions of the Royal Society of Tropical Medicine and Hygiene 2006; 100: 677-680.
2. WHO. Control of epidemic meningococcal disease. WHO practical guidelines, 2nd edn. WHO/EMC/ BAC/98.3:1. Geneva: World Health Organization, 1998.
3. Nicolas P, et al. Clonal expansion of sequence type (ST-)5 and emergence of ST-7 in serogroup A meningococci, Africa. Emerging Infections and Diseases 2001; 7: 849-854. (Pubitemid 33121592)
4. Caughant DA, Nicolas P. Molecular surveillance of meningococcal meningitis in Africa. Vaccine 2007; 25 (Suppl. 1): A8-11. (Pubitemid 47208590)
5. Nicolas P, et al. Molecular epidemiology of Neisseria meningitidis isolated in the African meningitis belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes. Journal of Clinical Microbiology 2005; 43: 5129-5135. (Pubitemid 41484016)
6. Teyssou R, Muros-Le Rouzic E. Meningitis epidemics in Africa: a brief overview. Vaccine 2007; 25 (Suppl. 1): A3-7. (Pubitemid 47198925)
7. Nicolas P, et al. Activity report 2008. Meningococcal Unit, WHO Collaborating Centre, Marseille, France, 2009, 23 pp.
8. World Health Organization. Meningitis in Chad, Niger and Nigeria: 2009 epidemic season. Weekly Epidemiological Record 2010; 85: 47-63.
9. Anon. Epidemiological situation of week 25 (15-21 June 2009). MDSC Meningitis Weekly Bulletin 2009 (http://www.who.int/csr/disease/meningococcal/ BulletinMeningite2009-S25.pdf) Accessed 26 August 2009.
10. Yaro S, et al. Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso. Clinical Infectious Diseases 2006; 43: 693-700. (Pubitemid 44330730)
11. LaForce MF, et al. Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution. Vaccine 2009; 27 (Suppl. 2): B13-19.
12. Campbell H, et al. Meningococcal C conjugate vaccine: the experience in England and Wales. Vaccine 2009; 27 (Suppl. 2): B20-29.